Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» HEPLISAV-B
HEPLISAV-B
FDA declines expanded use of Dynavax's hepatitis B vaccine on insufficient data
Reuters
Tue, 05/14/24 - 11:29 am
Dynavax Technologies
vaccines
hepatitis B
HEPLISAV-B
Watch These Biotechs and the FDA Calendar
TheStreet.com
Sun, 02/11/18 - 01:23 pm
FDA
biotech
Dynavax
HEPLISAV-B
Progenics
Azedra
Neurocrine
Elagolix
AbbVie
Watch These February Biotech Catalysts
Seeking Alpha
Thu, 02/1/18 - 09:58 am
biotech
Dynavax
HEPLISAV-B
vaccines
Novavax
NanoFlu
Nerlynx
Puma Biotechnology
breast cancer
Dynavax's hepatitis B vaccine gets FDA nod on third try, shares up
Reuters
Sat, 11/11/17 - 11:09 am
Dynavax
hepatitis B
vaccines
FDA
HEPLISAV-B
5 Biotech Stocks With Major Catalysts in July
Motley Fool
Wed, 06/28/17 - 11:03 pm
biotech
AcelRx
Zalviso
Alnylam
Patisiran
Dynavax
HEPLISAV-B
GSK
Benlysta
Puma Biotechnology
neratinib
The 'Gnarly 9' Biotechs Will Test the FDA's Mettle
TheStreet.com
Thu, 03/9/17 - 11:25 am
FDA
drug approvals
Alkermes
ALKS-5461
CytRx
aldoxorubicin
Dynavax Technologies
HEPLISAV-B
Intra-Cellular Therapies
ITI-007
Novan
SB204
Portola Pharmaceuticals
betrixaban
PTC Therapeutics
ataluren
Rigel Pharmaceuticals
fostamatinib
TG Therapeutics
ublituximab
Dynavax's stock plunges after disappointing FDA response to Hep-B treatment
Marketwatch
Mon, 11/14/16 - 11:41 am
Dynavax
hepatitis B
FDA
HEPLISAV-B
What Will Dynavax Do if Heplisav-B Is Rejected?
Motley Fool
Sun, 10/16/16 - 12:23 pm
Dynavax
HEPLISAV-B
vaccines
hepatitis B
FDA
Does This Upstart Pose a Threat to GlaxoSmithKline?
Motley Fool
Tue, 05/3/16 - 10:13 am
GSK
Dynavax Technologies
Engerix-B
hepatitis B
vaccines
HEPLISAV-B